 NEW YORK, Dec. 29, 2022 GLOBE NEWSWIRE Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating whether certain officers and directors of Nektar Therapeutics NASDAQ: NKTR breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. If you own ... The post Moore Kuehn, PLLC Encourages Investors of Nektar Therapeutics to Contact Law Firm appeared first on... 